Endo to Acquire Par Pharma for US$8.05 B to Become Top 5 US Generics Company
By Heather Cartwright & Rohit Khera
Pharma Deals Review: Vol 2015 Issue 6 (Table of Contents)
Published: 4 Jun-2015
DOI: 10.3833/pdr.v2015.i6.2106 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Continuing its pursuit of growth by acquisition, Endo International has agreed to buy privately held Par Pharmaceutical for US$8...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS